Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Orphenadrine Citrate 5 mg/mL Oral Suspension

FDA-approved generic
Dose form
Suspension
Active ingredients
Orphenadrine Citrate
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Orphenadrine Citrate
Suspension
66fd7b0bdc31c32733aec9f2
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded suspension containing orphenadrine citrate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing orphenadrine are listed in tablet and injection forms. No finished orphenadrine product of any kind is listed in suspension form.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Orphenadrine citrate is a centrally acting muscle relaxant with anticholinergic effects that a pharmacy may compound when a prescriber orders it.

About this ingredient

Orphenadrine is a centrally acting muscle relaxant and a methyl derivative of diphenhydramine. Its labels state that its mode of action has not been clearly identified, that it may be related to its pain-relieving properties, and that it does not directly relax tense skeletal muscles; it also has anticholinergic actions. Manufactured products include orphenadrine citrate extended-release tablets and orphenadrine citrate injection, given into a vein or muscle, both indicated as an add-on to rest, physical therapy and other measures for discomfort from acute painful musculoskeletal conditions. Norgesic Forte combines orphenadrine with aspirin and caffeine for mild to moderate pain of acute musculoskeletal disorders. A prescriber might order orphenadrine compounded in a form, strength or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Orphenadrine labels carry no boxed warning. Do not use it if you have glaucoma, a stomach or bowel blockage, stenosing peptic ulcers, an enlarged prostate or bladder neck blockage, megaesophagus (cardiospasm) or myasthenia gravis, or if you have had an allergic reaction to it. It can cause lightheadedness, dizziness or fainting, so avoid driving until you know how it affects you; MedlinePlus notes alcohol can worsen side effects and that adults 65 and older should not usually take it. Tell your prescriber about heart, liver or kidney disease. Confusion, anxiety and tremor have been reported with propoxyphene. The injection contains a sulfite that can cause allergic or asthma reactions in sensitive people. In pregnancy the label advises use only if clearly needed. LactMed notes no published breastfeeding data, that it might reduce milk production, and that another drug may be preferred. Talk to your prescriber or pharmacist about side effects.

LiverTox describes orphenadrine as a centrally acting, nonopiate analgesic and muscle relaxant with anticholinergic activity whose mechanism is not well defined and that may act centrally on pain perception. The labels state it does not directly relax tense skeletal muscle. Labeled indications: adjunct to rest, physical therapy and other measures for discomfort of acute painful musculoskeletal conditions (orphenadrine citrate extended-release tablets, ANDA, and orphenadrine citrate injection for intravenous or intramuscular use, ANDA), and, in combination with aspirin and caffeine, mild to moderate pain of acute musculoskeletal disorders (Norgesic Forte, ANDA, which carries aspirin warnings including Reye's syndrome). Adverse effects are mainly anticholinergic and dose related: tachycardia, urinary retention, blurred vision, raised intraocular pressure, confusion in elderly patients. Use caution in tachycardia, cardiac decompensation, coronary insufficiency and arrhythmias. Safety of continuous long-term use is not established; the label recommends periodic blood, urine and liver function monitoring with prolonged use. The label notes chronic abuse for euphoric effects and an unpredictable toxic range in overdose. LiverTox rates it an unlikely cause of clinically apparent liver injury. Pediatric safety is not established. Orphenadrine is not a controlled substance on these labels. Dosing is per prescriber.

Sources

Using and storing

How it is used

Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.

Storing it

Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Orphenadrine Citrate 5 mg/mL Oral Suspension
Suspension
30 mL
controlled

Take orally

Twice daily